Year: 2025

CRML Announces Another Set of Outstanding Rare Earth Elements Results From Its 2024 Drilling Program at Tanbreez. These Elements & Results Include: Niobium Pentoxide of Up to 1,746 ppm, Cerium Dioxide 1711 ppm, Gallium 103 ppm & Hafnium 484 ppm- Mineralisation Has Been Confirmed to Occur Consistently Across All Drilling Locations and at Surface

Written by Customer Service on December 15, 2025. Posted in Public Companies.

GREENLAND, TANBREEZ ASSET DRILLING REE HIGHLIGHTS: Consistent Rare Earth Grades: TREO grades range from 0.39% to 0.54%, with heavy rare earth oxides (HREO) representing approximately ~25–27% TREO. Strategic Metals: Gallium oxide (~97 ppm), hafnium oxide (~350 ppm), yttrium oxide (~742 ppm), and cerium oxide (~1,630 ppm) are consistently present, alongside zirconium (1.55–1.97%), niobium, and tantalum—supporting multi-commodity potential. Potential: The Fjord area remains open along strike and demonstrates strong vertical grade continuity, indicating significant potential for resource growth. Mineralisation is confirmed to occur consistently from surface. A1-24 40m @ 0.48% TREOY (27% HREO) 103ppm Ga2O5, 403ppm HfO2, 1711ppm CeO2, 1513ppm Nb2O5 A2-24 41m @ 0.51% TREOY (27% HREO), 96ppm Ga2O5, 393ppm HfO2, 1850ppm CeO2, 1685ppm...

iStock Reveals the Visual Marketing Trends That Will Shape SMB growth in 2026

Written by Customer Service on December 15, 2025. Posted in Public Companies.

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) — iStock, a leading ecommerce platform providing premium content to SMBs, SMEs, creatives, and students everywhere, has released its 2026 Marketing Trends, unpacking the visual and cultural trends that will guide how SMBs create, communicate, and compete in 2026. As generative AI tools accelerate content creation, brands of every size are under growing pressure to stand out—making visual strategy more essential than ever. According to iStock’s VisualGPS research, six out of ten people now say they distrust the advertising they see, largely because they believe it is AI-generated, manipulated, or inauthentic. For SMBs this trust gap creates both a challenge and an opportunity: audiences are consuming more content than ever, but they’re also demanding greater credibility, originality, and...

BRMG, a Hover Group Company, Ends 2025 with Strong Foundation and Expanding Operator Pipeline Ahead of 2026 Scale-Up

Written by Customer Service on December 15, 2025. Posted in Earnings Releases And Operating Results.

BRMG, a Hover Group company, today announced its Q4 and fiscal year-end results, closing FY2025 with a strengthened operating foundation, accelerated growth, and clear momentum heading into FY26. TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — The company delivered significant year-over-year revenue growth, representing a 133% increase from FY2024. This surge reflects the strong market adoption of BRMG’s Operator-first model, which continues to attract senior practitioners seeking independence, alignment, and a modern alternative to traditional agency structures. Throughout the year, BRMG Operators also surpassed a key performance milestone: each Operating Partner achieved an annual portfolio value above all targets, demonstrating both the maturity of the model and the strength of client demand across the network. BRMG ended FY2025 performing...

CubeSmart Announces 1.9% Increase in Quarterly Common Dividend

Written by Customer Service on December 15, 2025. Posted in Dividend Reports And Estimates.

MALVERN, Pa., Dec. 15, 2025 (GLOBE NEWSWIRE) — CubeSmart (NYSE: CUBE) announced today that its Board of Trustees declared a quarterly dividend of $0.53 per common share for the period ending December 31, 2025. The dividend is payable on January 16, 2026 to common shareholders of record on January 2, 2026. “We are pleased to announce the 16th consecutive annual increase to our dividend,” commented President and Chief Executive Officer Christopher P. Marr. About the Company CubeSmart is a self-administered and self-managed real estate investment trust. CubeSmart owns or manages 1,527 self-storage properties across the United States. According to the 2025 Self Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the U.S. The Company’s mission is to simplify the organizational and logistical...

Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma

Written by Customer Service on December 15, 2025. Posted in Public Companies.

Promising data show a median overall survival of 18.6 months, with 40% of patients alive at 2 years. Results suggest that nuclear GSK-3β expression may help identify patients most likely to respond to treatment of a historically difficult-to-treat refractory disease CHICAGO and FORT WORTH, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), today announced the publication of new data in Clinical Cancer Research from a Phase II study (NCT05010629) evaluating elraglusib in combination with carboplatin or cisplatin (with or without sequential pembrolizumab priming) in patients...

VivoPower to Originate 450 Million Underlying XRP Tokens Worth an Estimated $900 Million for Lean Ventures Through Targeted Ripple Labs Share Purchase

Written by Customer Service on December 15, 2025. Posted in Public Companies.

Lean Ventures has engaged VivoPower’s digital asset unit, Vivo Federation to originate $300 million of Ripple Labs shares Translates into an estimated 450 million underlying XRP tokens with a current market value of approximately $900 million LONDON, Dec. 15, 2025 (GLOBE NEWSWIRE) — VivoPower International PLC’s (NASDAQ: VVPR) (the “Company”), digital asset unit, Vivo Federation, as part of a recently announced joint venture partnership, has been engaged to originate an initial $300 million worth of Ripple Labs shares for its South Korean asset management partner, Lean Ventures, an established and licensed South Korean asset manager, headquartered in Seoul. This translates to approximately 450 million underlying XRP tokens, worth an estimated $900 million at the current XRP spot price. Vivo Federation will receive a...

AITX Announces Expanding Offering and Increasing Focus on Agentic AI Solution

Written by Customer Service on December 15, 2025. Posted in Public Companies.

Industry Input Refines SARA for Focus on Quick and Easy Adoption Scale Detroit, Michigan, Dec. 15, 2025 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, reports accelerating momentum across its SARA™ ecosystem as industry adoption increasingly reflects years of deliberate development combined with direct input from security and monitoring operators. As organizations seek greater intelligence, automation, and decision velocity, the Company sees growing recognition of SARA’s expanding role as a unifying intelligence layer designed to operate at scale while fitting more naturally into real world monitoring workflows. SARA, which stands for Speaking Autonomous Responsive Agent, is AITX’s multiple award-winning...

ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders’ Meeting

Written by Customer Service on December 15, 2025. Posted in Public Companies.

37.8% of voting rights present or represented All resolutions were approvedMADRID and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, today announced the results of voting at the Extraordinary General Shareholders’ Meeting held last Friday in Madrid. A total of 33,581,589 of the Company’s issued and outstanding voting rights (representing 37.7938% of the share capital) were at the Meeting, either in person or represented by proxy. The Company’s shareholders approved all of the resolutions listed below, proposed by the Board of Directors at the Company’s Extraordinary General Shareholders’ Meeting, with favorable votes ranging from 93% to 98%.Technical amendment of Article...

SPIE signs a European framework agreement with Tesla for the deployment of battery energy storage systems (BESS)

Written by Customer Service on December 15, 2025. Posted in Public Companies.

Cergy, France, 15 December 2025 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the signing of a European framework agreement with Tesla relating to the implementation of battery energy storage system (BESS) projects. This agreement, with a renewable term of three years, applies to all European SPIE group subsidiaries with BESS installation expertise. It strengthens the collaboration between the two companies that is founded on several completed or ongoing projects in Belgium, the Netherlands and France. The agreement showcases the SPIE group’s ability to implement structured project organisation to manage strategic projects. A single framework to support the growth of energy storage in Europe Energy storage is a vital component of the energy transition, enabling...

CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China

Written by Customer Service on December 15, 2025. Posted in Public Companies.

SHENZHEN, CHINA, Dec. 15, 2025 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for an independent listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement of the Company dated 22 April 2025 for details), has obtained the relevant licensing rights to the innovative oral JAK1 inhibitor povorcitinib (proposed English generic name: Povorcitinib Phosphate Tablets) (“povorcitinib” or the “Product”), which has been included in the list of Breakthrough Therapeutic Drugs by the Center for Drug Evaluation of the National Medical Products Administration of the People’s Republic of China (“NMPA”), with...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals